File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.xcrm.2024.101489
- Scopus: eid_2-s2.0-85189156101
- PMID: 38554705
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages
Title | Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages |
---|---|
Authors | Deng, YulanXia, LiangZhang, JianDeng, SenyiWang, MengyaoWei, ShiyouLi, KaixiuLai, HongjinYang, YunhaoBai, YuquanLiu, YongchengLuo, LanzhiYang, ZhenyuChen, YaohuiKang, RanGan, FanyiPu, QiangMei, JiandongMa, LinLin, FengGuo, ChenglinLiao, HuZhu, YunkeLiu, ZhengLiu, ChengwuHu, YangYuan, YongZha, ZhengyuYuan, GangZhang, GaoChen, LuonanCheng, QingShen, ShensiLiu, Lunxu |
Issue Date | 16-Apr-2024 |
Publisher | Cell Press |
Citation | Cell Reports Medicine, 2024, v. 5, n. 4 How to Cite? |
Abstract | Lung adenocarcinoma is a type of cancer that exhibits a wide range of clinical radiological manifestations, from ground-glass opacity (GGO) to pure solid nodules, which vary greatly in terms of their biological characteristics. Our current understanding of this heterogeneity is limited. To address this gap, we analyze 58 lung adenocarcinoma patients via machine learning, single-cell RNA sequencing (scRNA-seq), and whole-exome sequencing, and we identify six lung multicellular ecotypes (LMEs) correlating with distinct radiological patterns and cancer cell states. Notably, GGO-associated neoantigens in early-stage cancers are recognized by CD8+ T cells, indicating an immune-active environment, while solid nodules feature an immune-suppressive LME with exhausted CD8+ T cells, driven by specific stromal cells such as CTHCR1+ fibroblasts. This study also highlights EGFR(L858R) neoantigens in GGO samples, suggesting potential CD8+ T cell activation. Our findings offer valuable insights into lung adenocarcinoma heterogeneity, suggesting avenues for targeted therapies in early-stage disease. |
Persistent Identifier | http://hdl.handle.net/10722/348608 |
ISSN | 2023 Impact Factor: 11.7 2023 SCImago Journal Rankings: 4.276 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Deng, Yulan | - |
dc.contributor.author | Xia, Liang | - |
dc.contributor.author | Zhang, Jian | - |
dc.contributor.author | Deng, Senyi | - |
dc.contributor.author | Wang, Mengyao | - |
dc.contributor.author | Wei, Shiyou | - |
dc.contributor.author | Li, Kaixiu | - |
dc.contributor.author | Lai, Hongjin | - |
dc.contributor.author | Yang, Yunhao | - |
dc.contributor.author | Bai, Yuquan | - |
dc.contributor.author | Liu, Yongcheng | - |
dc.contributor.author | Luo, Lanzhi | - |
dc.contributor.author | Yang, Zhenyu | - |
dc.contributor.author | Chen, Yaohui | - |
dc.contributor.author | Kang, Ran | - |
dc.contributor.author | Gan, Fanyi | - |
dc.contributor.author | Pu, Qiang | - |
dc.contributor.author | Mei, Jiandong | - |
dc.contributor.author | Ma, Lin | - |
dc.contributor.author | Lin, Feng | - |
dc.contributor.author | Guo, Chenglin | - |
dc.contributor.author | Liao, Hu | - |
dc.contributor.author | Zhu, Yunke | - |
dc.contributor.author | Liu, Zheng | - |
dc.contributor.author | Liu, Chengwu | - |
dc.contributor.author | Hu, Yang | - |
dc.contributor.author | Yuan, Yong | - |
dc.contributor.author | Zha, Zhengyu | - |
dc.contributor.author | Yuan, Gang | - |
dc.contributor.author | Zhang, Gao | - |
dc.contributor.author | Chen, Luonan | - |
dc.contributor.author | Cheng, Qing | - |
dc.contributor.author | Shen, Shensi | - |
dc.contributor.author | Liu, Lunxu | - |
dc.date.accessioned | 2024-10-11T00:30:46Z | - |
dc.date.available | 2024-10-11T00:30:46Z | - |
dc.date.issued | 2024-04-16 | - |
dc.identifier.citation | Cell Reports Medicine, 2024, v. 5, n. 4 | - |
dc.identifier.issn | 2666-3791 | - |
dc.identifier.uri | http://hdl.handle.net/10722/348608 | - |
dc.description.abstract | Lung adenocarcinoma is a type of cancer that exhibits a wide range of clinical radiological manifestations, from ground-glass opacity (GGO) to pure solid nodules, which vary greatly in terms of their biological characteristics. Our current understanding of this heterogeneity is limited. To address this gap, we analyze 58 lung adenocarcinoma patients via machine learning, single-cell RNA sequencing (scRNA-seq), and whole-exome sequencing, and we identify six lung multicellular ecotypes (LMEs) correlating with distinct radiological patterns and cancer cell states. Notably, GGO-associated neoantigens in early-stage cancers are recognized by CD8+ T cells, indicating an immune-active environment, while solid nodules feature an immune-suppressive LME with exhausted CD8+ T cells, driven by specific stromal cells such as CTHCR1+ fibroblasts. This study also highlights EGFR(L858R) neoantigens in GGO samples, suggesting potential CD8+ T cell activation. Our findings offer valuable insights into lung adenocarcinoma heterogeneity, suggesting avenues for targeted therapies in early-stage disease. | - |
dc.language | eng | - |
dc.publisher | Cell Press | - |
dc.relation.ispartof | Cell Reports Medicine | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.xcrm.2024.101489 | - |
dc.identifier.pmid | 38554705 | - |
dc.identifier.scopus | eid_2-s2.0-85189156101 | - |
dc.identifier.volume | 5 | - |
dc.identifier.issue | 4 | - |
dc.identifier.eissn | 2666-3791 | - |
dc.identifier.issnl | 2666-3791 | - |